On the other hand, it is unlikely that the anti-proliferative effects of PINO could be due to the activation of ERβ because both breast cancer cells tested MDA-MB-231 and MCF7, express low levels of this receptor [34]. The gene discussed is ESR2; the disease is breast carcinoma.